2014 AACI Clinical Research Initiative Meeting Abstract (2 pages)
2014 AACI Clinical Research Initiative Meeting Abstract
Abstract Title: How the ACA Could Affect Accrual to Oncology Clinical Trials at a Midwest NCI Designated
Author Names: Christine Mackay, BSN, RN, MSA, CCRP; Kirsten Erickson, PhD; Maxine Stoltz, PhD; Tami-
Cancer Center Name: University of Kansas Cancer Center
Describe the background of the problem:
Sixteen states, including Kansas, do not have any state requirements for insurance providers to cover
participation in clinical trials. Lack of insurance coverage for routine procedures for adult cancer
patients wishing to receive treatment through a clinical trial has been identified as a significant
participation barrier. The expectation of the oncology community was that the Affordable Care Act
(ACA) would eliminate this barrier, however little is known about how the ACA mandating (a) most
United States citizens to have health care insurance and (b) insurance companies to cover the cost of
routine procedures in clinical trials will impact the number of individuals with coverage to participate in
Provide metrics or goals hoped to be achieved with the solutions to address the problem:
The objective of this analysis was to estimate the number of Kansans who have health insurance
coverage for participation in oncology clinical trials following the implementation of the ACA individual
mandate. Examining the status of health insurance coverage of adult Kansans should enhance our ability
to predict the number of individuals for whom insurance may no longer be a barrier for receiving
treatment as part of a cancer clinical trial.
Describe the solutions or methods implemented:
This cross-sectional study utilized the 2012 American Community Survey, Public Use Microdata Sample
(PUMS), from the United States (US) Census Bureau as well as the Health and Human Services Health
Insurance Marketplace enrollment report dated May 1, 2014. Kansans aged 19 to 64 years old are
included in the analysis by insurance status. Three cohorts were developed based on type of insurance:
commercial (employer or union sponsored, purchased directly from insurance company); government
(Medicare, Medicaid, TriCare, VA); or no coverage.
Describe the outcome of the solutions implemented or show data representing a change whether
positive or negative.
Results from this analysis show an increase of Kansans aged 19 to 64 that have commercial health
insurance coverage for participation in qualifying clinical trials following the enactment of the individual
mandate of the ACA (Most current results will be included in the poster).
Show lessons learned, others to involve in the future, changes to the methods to achieve a better